The impact of HLA-A matching on long-term survival of renal allografts

Transplantation
F A ZantvoortJ Thorogood

Abstract

An important contribution of HLA-A antigen matching in renal transplantation was reported initially, hut later publications showed a minor or absent role. We analyzed the contribution of HLA-A locus matching to graft survival in 17,672 first renal transplants from unrelated, nonliving donors. We show that an independent HLA-A matching effect still exists. Due to its relative weakness and late appearance, large numbers and longer follow-up periods are required. The HLA-A matching effect is a significant factor in first renal allograft survival up to 6 years after transplantation, with an increasing effect over time. This is in contrast to the strong, short-lived, effects of HLA-DR and -B matching, which can only be detected up to 6 months and 2 years after transplantation, respectively. A clear additive beneficial effect of HLA-A matching is shown in the group without B and DR mismatches. Therefore, prospective matching for the HLA-A antigens remains important for renal allograft survival.

Citations

Aug 1, 1997·Human Immunology·J M Cecka
Jun 26, 1998·Transplant Immunology·A J Matas
Nov 5, 1999·The New England Journal of Medicine·J H Helderman, S Goral
Mar 10, 2001·Transplantation·J W van den BergW van der Bij
Jan 28, 2003·Transplantation·Yvo W J SijpkensLeendert C Paul
Feb 12, 1998·Tissue Antigens·C B Carpenter
Jul 11, 2012·Journal of Transplantation·Marco Antonio Ayala GarcíaEduardo Guaní Guerra
Feb 1, 1997·Transplantation Proceedings·T Wujciak, G Opelz
Dec 18, 2004·Human Immunology·Steve TakemotoRene J Duquesnoy
Jan 18, 2006·Advances in Chronic Kidney Disease·Pankaj BalujaZoltan Laszik
Feb 22, 2017·Transplantation·Malek KamounRobert M Merion
Feb 18, 2003·Transplantation·Marlies K A DankersFrans H J Claas
Oct 3, 2018·Plastic and Reconstructive Surgery. Global Open·Jessica B ChangDaniel J Ceradini
Mar 27, 2020·Journal of Tissue Engineering and Regenerative Medicine·Kyungsook KimTeruo Okano
Oct 22, 2002·Transplant International : Official Journal of the European Society for Organ Transplantation·Michael J DickenmannGilbert Thiel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.